Literature DB >> 789253

[The liver concentration of cephradin and cephacetril and their elimination in the bile].

D Maroske, H Knothe, A Rox.   

Abstract

Liver biopsies and serum samples were collected after intravenous application of 2 g cephradin (n = 13) or 2 g cephacetril (n = 11) during surgery. There was no difference in the serum levels of cephradin and cephacetril. 30 min. after i.v. application of cephradin the liver tissue concentration was 72.62 mcg/g. 30 min. after i.v. cephacetril the liver tissue concentration was 5.83 mcg/g. The quotient of liver tissue concentration to serum concentration for cephradin was between 0.36 and 0.83, and for cephacetril between 0.02 and 0.16. The excretion of cephradin and cephacetril in human bile was studied by collecting bile samples from the common bile duct via T-tube drainage (n = 17). Cholecystomized patients were given 2 g of antibiotics intravenously. Serum levels of cephradin were 263 mcg/ml 5 min after application, and 22 mcg/ml after 240 min. Serum levels of cephradin were 263 mcg/ml 5 min after application, and 22 mcg/ml after 240 min. Serum levels of cephacetril were 193 mcg/ml 5 min after application, and 27 mcg/ml after 240 min. The highest levels of cephradin in the bile were found 75 min after injection at a concentration of 86.4 mcg/ml; the highest level for cephacetril was 21.8 mcg/ml at 15 min. In patients with hyperbilirubinaemia cephradin reached a mean maximum concentration of 29.6 mcg/ml in bile samples, in comparison to 117.4 mcg/ml in normal patients, while no difference was seen with cephacetril. After intravenous administration of 2 g cephradin biliary concentration are achieved which may be sufficiently high to be effective not only against the very sensitive gram-positive organisms, but also against most strains of E. coli, Klebsiella and indol-negative Proteus. Cephradin is effective in the treatment of cholangitis and intrahepatic abscesses, as was observed in 18 patients. A free bile-flow is essential.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 789253     DOI: 10.1007/bf01638943

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  7 in total

1.  [Clinical study on the new derivative of cephalosporine called cefradine].

Authors:  O C von Perjés
Journal:  Med Welt       Date:  1974-09-27

2.  The biliary excretion of cephalothin.

Authors:  J M Brogard; P Haegele; J J Kohler; M Dorner; J Lavillaureix; J Stahl
Journal:  Chemotherapy       Date:  1973       Impact factor: 2.544

3.  [Biliary elimination of cephaloridine. Pharmacokinetic, experimental and clinical data].

Authors:  J M Brogard; P Haegele; M Dorner; J Lavillaureix
Journal:  Ann Biol Clin (Paris)       Date:  1972       Impact factor: 0.459

4.  [Detemination of cephalexin in serum, urine, bile, peritoneal exudate and bone marrow].

Authors:  W Irmer; D Lubach; U Sucker
Journal:  Dtsch Med Wochenschr       Date:  1971-03-12       Impact factor: 0.628

5.  [Experimental trials with the new cephalosporin antibiotic celospor (Cephacetril)].

Authors:  F Kradolfer; T Ahrens; J Gelzer; W Vischer; W Zimmermann
Journal:  Schweiz Med Wochenschr       Date:  1973-05-12

6.  Cephalexin levels in human bile in presence of biliary tract disease.

Authors:  J E Sales; M Sutcliffe; F O'Grady
Journal:  Br Med J       Date:  1972-08-19

7.  [Blood distribution, renal and biliary excretion of a new caphalosporin, cephacetrile (Ciba 36278 Ba)].

Authors:  J M Brogard; F Kuntzmann; J Lavillaureix
Journal:  Schweiz Med Wochenschr       Date:  1973-01-20
  7 in total
  1 in total

1.  [An investigation into the influence of human serum on the in-vitro activity of various cephalosporins (author's transl)].

Authors:  R Ratschow; J R Krone
Journal:  Infection       Date:  1977       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.